PLUR
PLUR
NASDAQ · Biotechnology

Pluri Inc

$3.07
+0.02 (+0.66%)
As of Mar 25, 5:06 PM ET ·
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Buy 6 86%
Hold 1 14%
Sell 0 0%
Price Target
Analyst Price Target +1,283.7% upside
Low Target $23.35
Average Target $42.48
High Target $52.53
Current Price $3.07
Current
$3.07
Target
$42.48
$23.35 $42.48 avg $52.53
Scenario Analysis
Bear Case
$23.35
660.6%
Low target
Base Case
$42.48
+1,283.7%
Avg target
Bull Case
$52.53
+1,611.1%
High target
Risk/Reward
2.4x
Favorable
Price in Context
52-Week High
$7.13
-56.9% from high
52-Week Low
$2.82
+8.9% from low
Target vs 52W High
$42.48
+495.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +24.3%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.1%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.3%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -3.7%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.8%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -3.3%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -27.6%